Effects of Ca2+ channel blockers on Ca2+ loading induced by metabolic inhibition and hyperkalemia in cardiomyocytes

European Journal of Pharmacology

Volumn 360, Issue 2-3, 1998, Pages 205-211

  Tang, Tianlai ^a   Duffield, Rose ^a   Ho, Andrew K S ^a  

^a Division of Clinical Pharmacology   (United States)

Author keywords

Ca2+ channel blocker; Ca2+, intracellular; Cardiomyocyte; Cyanide; Hyperkalemia; Ryanodine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FURA 2; MIBEFRADIL; NIFEDIPINE; RYANODINE; VERAPAMIL; BENZIMIDAZOLE DERIVATIVE; CALCIUM; CYANIDE; POTASSIUM; POTASSIUM CHLORIDE; TETRALIN DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE; HEART MUSCLE CELL; HYPERKALEMIA; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; HEART MUSCLE; METABOLISM;

ANIMALS; BENZIMIDAZOLES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CHICKENS; CYANIDES; HYPERKALEMIA; MIBEFRADIL; MYOCARDIUM; POTASSIUM; POTASSIUM CHLORIDE; RYANODINE; TETRAHYDRONAPHTHALENES; VERAPAMIL;

EID: 0032491311     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00657-8     Document Type: Article

References (27)

1. Chouariri S., Carrie D., Puel J. Myocardial protection with calcium-channel blockers during ischemia and reperfusion by PTCA. Eur. Heart J. 16:1995;3-8. Suppl. H.
2. Cyran S.E., Ditty S.E., Baylen B.G., Cheung J., LaNoue K.F. Developmental differences in the response of cytosolic free calcium to potassium depolarization and cardioplegia in ventricular myocytes. J. Mol. Cell Cardiol. 24:1992;1189-1194.
3. Feher J.J., LeBolt W.R., Manson N.H. Differential effect of global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ. Res. 65:1989;1400-1408.
4. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation. 92(5):1995;1326-1331.
5. 2+ antagonist in cardioplegic arrest. Jpn. Circ. J. 57(3):1993;237-244.
6. 2+ transients in rat and canine cardiomyocytes. J. Mol. Cell Cardiol. 29(3):1997;1037-1043.
7. Jiang G., Mochizuki S., Pool-Wilson P.A., Harding S.E., Macleod K.T. Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc. Res. 28:1994;851-857.
8. Katz A.M., Reuter H. Cellular calcium and cardiac cell death. Am. J. Cardiol. 44:1979;188-190.
9. 2+ mobilization from inositol triphosphate-insensitive pools. Toxical. Appl. Pharmcol. 127:1994;173-181.
10. Lopez J.R., Jahangir R., Jahangir A., Shen W.K., Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J. Thorac. Cardiovasc. Surg. 112(3):1996;820-831.
11. Massie B.M. Mibefridil: a selective T-type calcium antagonist. Am. J. Cardiol. 80(9a):1997;23I-32I.
12. 2+-ATPase on cytoplasmic calcium and enzyme secretion in pancreatic acini. Biochim. Biophys. Acta. 13;1220(2): 199-208.
13. Naylor W.G. The role of calcium in the ischemic myocardium. Am. J. Pathol. 102:1981;262-270.
14. Psaty B.M., Heckbert S.R., Koepsell T.D., Siscovick D.S., Raghunathan T.E., Weiss N.S., Rosendaal F.R., Lemaitre R.N., Smith N.L., Wahl P.W. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 274(8):1995;620-625.
15. Richard V., Tron C., Blanc T., Thuillez C. Infarct size-limiting properties of Ro 40-5967, a novel nondihydropyridine calcium channel, in anesthetized rats: comparison with verapamil. J. Cardiovasc. Pharmacol. 25(4):1995;552-557.
16. Rios E., Pizarro G. Voltage sensor of excitation-contraction coupling in skeletal muscle. Physiol. Rev. 71:1991;849-908.
17. Rios E., Karhanek M., Ma J. An allosteric model of the molecular interactions of excitation-contraction coupling in skeletal muscle. J. Gen. Physiol. 102:1993;449-481.
18. Schneider M.F. Control of calcium release in functioning skeletal muscle fibers. Annu. Rev. Physiol. 56:1994;463-484.
19. Shattock M.J., Bers D.M. Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am. J. Physiol. 256:1989;C813-C822.
20. Steenbergen C., Murphy E., Levy L., London R.E. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ. Res. 60:1997;700-707.
21. 2+-overload in reperfused ischemic myocardium. Annu. Rev. Physiol. 52:1990;543-559.
22. + by rat heart homogenate blocked by ryanodine. Cardiovasc. Res. 31:1996;263-269.
23. Tenthorey D., de Ribaupierre Y., Kucera P., Raddatz E.J. Effects of verapamil and ryanodine on activity of the embryonic chick heart during anoxia and reoxygenation. Cardiovasc. Pharmacol. 31(2):1998;195-202.
24. Tsukube T., McCully J.D., Federman M., Krukenkamp I.B., Levitsky S. Developmental differences in cytosolic calcium accumulation associated with surgically induced global ischemia: optimization of cardioplegic protection and mechanism of action. J. Thorac. Cardiovasc. Surg. 112(1):1996;175-184.
25. Vigne P., Breittmayer J.P., Frelin C. Thapsigargin, a new inotropic agent, antagonizes action of endothelin-1 in rat atrial cells. Am. J. Physiol. 263:1992;H1689-H1694.
26. + channel. Cir. Res. 67:1990;835-843.
27. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacological Rev. 49(1):1997;1-51.